Your browser doesn't support javascript.
loading
A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.
Gatti-Mays, Margaret E; Tschernia, Nicholas P; Strauss, Julius; Madan, Ravi A; Karzai, Fatima H; Bilusic, Marijo; Redman, Jason; Sater, Houssein Abdul; Floudas, Charalampos S; Toney, Nicole J; Donahue, Renee N; Jochems, Caroline; Marté, Jennifer L; Francis, Deneise; McMahon, Sheri; Lamping, Elizabeth; Cordes, Lisa; Schlom, Jeffrey; Gulley, James L.
Afiliação
  • Gatti-Mays ME; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Tschernia NP; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Strauss J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Madan RA; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Karzai FH; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Bilusic M; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Redman J; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Sater HA; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Floudas CS; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Toney NJ; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Donahue RN; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Jochems C; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Marté JL; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Francis D; Office of Research Nursing, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
  • McMahon S; Office of Research Nursing, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
  • Lamping E; Office of Research Nursing, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
  • Cordes L; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Schlom J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Gulley JL; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Oncologist ; 28(4): 364-e217, 2023 04 06.
Article em En | MEDLINE | ID: mdl-36640137

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos